Multiple myeloma: open trials in South Africa

• NCT05519085

  A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  Trial Treatment · Phase 3 · Celgene

  Cape Town · Centurion · Kuilsriver · Plumstead

  Registry updated 2026-10-30

• NCT05714839

  A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

  Trial Treatment · Phase 1/2 · GlaxoSmithKline

  Kuils River

  Registry updated 2026-08-19

• NCT06679101

  A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

  Trial Treatment · Phase 3 · GlaxoSmithKline

  Kuils River · Pretoria

  Registry updated 2026-04-22

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error